Literature DB >> 1518737

Bacterial endocarditis in children: trends in its diagnosis, course, and prognosis.

D Hansen1, K Schmiegelow, J R Jacobsen.   

Abstract

In a population-based study of 41 children with bacterial endocarditis (BE), diagnosed in the period 1970 through 1989 in eastern Denmark, we analyzed trends in the diagnosis of BE and in mortality, and searched for possible prognostic factors. During this period the delay in diagnosis from first symptom to treatment did not change, but the delay from admission to treatment was significantly prolonged from 0 to 3 days, despite the introduction of echocardiography (ECHO). There was a significant improvement in the prognosis, the mortality rate having decreased from 40 to 0% [95% confidence limits: 12-74 vs. 0-26 (0.01 less than p less than 0.02)]. The improved prognosis was not explained by changes in the etiology or pattern of antibiotic resistance and may reflect a milder course of BE in children. Children with "mild anomalies"--such as bicuspid aortic valve (n = 5), coarctation of the aorta (n = 2), and prolapse of the mitral valve (n = 2)--had a significantly poorer prognosis than children with other forms of congenital heart disease (CHD) (p = 0.004), a reminder of the importance of suspecting BE in all children with unexplained long-lasting or intermittent fever, because some may have unrecognized "mild" CHD.

Entities:  

Mesh:

Year:  1992        PMID: 1518737     DOI: 10.1007/BF00838776

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  13 in total

1.  The congenitally bicuspid aortic valve. A study of 85 autopsy cases.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1970-07       Impact factor: 2.778

2.  Current clinical aspects of bacterial endocarditis in infancy, childhood, and adolescence.

Authors:  H H Kramer; M Bourgeois; R Liersch; H Kuhn; L Nessler; H Meyer; G Sievers
Journal:  Eur J Pediatr       Date:  1983 Jun-Jul       Impact factor: 3.183

3.  Pediatric bacterial endocarditis. Long-term follow-up.

Authors:  R G Fisher; D S Moodie; R Rice
Journal:  Cleve Clin Q       Date:  1985

4.  A forty-year review of bacterial endocarditis in infancy and childhood.

Authors:  D H Johnson; A Rosenthal; A S Nadas
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

5.  Infective endocarditis in children with congenital heart disease: comparison of selected features in patients with surgical correction or palliation and those without.

Authors:  T Karl; D Wensley; J Stark; M de Leval; P Rees; J F Taylor
Journal:  Br Heart J       Date:  1987-07

6.  Infectious endocarditis in children.

Authors:  F Parras; E Bouza; J Romero; L Buzón; M Quero; J Brito; D Vellibre
Journal:  Pediatr Cardiol       Date:  1990-04       Impact factor: 1.655

7.  Two-dimensional echocardiographic assessment of infective endocarditis in children.

Authors:  R E Kavey; D M Frank; C J Byrum; M S Blackman; H M Sondheimer; E L Bove
Journal:  Am J Dis Child       Date:  1983-09

8.  Pediatric endocarditis.

Authors:  C M Johnson; K H Rhodes
Journal:  Mayo Clin Proc       Date:  1982-02       Impact factor: 7.616

9.  Infective endocarditis in childhood.

Authors:  G F Sholler; R E Hawker; J M Celermajer
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

10.  Infective endocarditis in Swedish children. II. Location, major complications, laboratory findings, delay of treatment, treatment and outcome.

Authors:  J Schollin; B Bjarke; G Wesström
Journal:  Acta Paediatr Scand       Date:  1986-11
View more
  2 in total

Review 1.  Infective endocarditis in congenital heart disease.

Authors:  Walter Knirsch; David Nadal
Journal:  Eur J Pediatr       Date:  2011-07-20       Impact factor: 3.183

2.  The changing epidemiology of pediatric endocarditis at a children's hospital over seven decades.

Authors:  Lauren B Rosenthal; Kristina N Feja; Stéphanie M Levasseur; Luis R Alba; Welton Gersony; Lisa Saiman
Journal:  Pediatr Cardiol       Date:  2010-04-23       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.